NeuroSense Therapeutics (NRSN) Earnings Date & Reports

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

NRSN is expected to report earnings to fall 82.77% to -4 cents per share on June 22

NeuroSense Therapeutics NRSN Stock Earnings Reports

Q1'26

Est.

$-0.04

Q4'25

Missed

by $0.13

Q3'25

Beat

by $0.02

Q2'25

Beat

by $0.09

Q1'25

Beat

by $0.04

The last earnings report on March 31 showed earnings per share of -23 cents, missing the estimate of -10 cents. With 102.14K shares outstanding, the current market capitalization sits at 27.08M.

View a ticker or compare two or three

Compare

NRSN

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for NRSN